Thompson Siegel & Walmsley’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
RC
WHG
PIM
Thompson Siegel & Walmsley's AVNS Position: Q1 2024 in Review
Thompson Siegel & Walmsley sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 40 shares — an estimated $1K sold.
Thompson Siegel & Walmsley first reported a position in AVNS in Q4 2014 and held it in 31 quarters. The position peaked at $44K in Q1 2015. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.
- Thompson Siegel & Walmsley reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
- Thompson Siegel & Walmsley sold 40 Avanos Medical shares in Q1 2024, an estimated $1K.
- Thompson Siegel & Walmsley first reported a position in Avanos Medical in Q4 2014 and held it in 31 quarters.
- Thompson Siegel & Walmsley's Avanos Medical position peaked at $44K in Q1 2015.
- 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.
Based on Thompson Siegel & Walmsley's 13F filing for Q1 2024, filed 9 May 2024.